Introduction
Medicare and Medicaid are essential public health-insurance programs, but their size and complexity also make them vulnerable to fraud, waste, abuse, overpayment, billing errors, and conflicts of interest. Medicare primarily serves older adults and certain younger people with disabilities, while Medicaid covers many low-income adults, children, pregnant people, older adults, and people with disabilities under federal-state rules that vary by state. Problems in these programs should not be reduced to a simple claim that beneficiaries are receiving too much care or that private companies are inherently harmful. Public programs depend on hospitals, physicians, pharmacies, insurers, contractors, and technology vendors, all of which can contribute valuable services while also creating opportunities for financial misconduct or weak oversight. The central policy issue is how to protect beneficiaries and taxpayers without making legitimate care harder to obtain.
How Fraud and Improper Billing Harm Public Programs
Healthcare fraud can involve billing for services that were never provided, misrepresenting diagnoses or procedures, paying kickbacks for referrals, submitting claims under stolen identities, providing medically unnecessary services, or diverting payments intended for legitimate providers. The U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG) investigates fraud, waste, abuse, and mismanagement across Medicare, Medicaid, and other federal health programs. Its enforcement work shows that fraud is not limited to one type of provider or one billing scheme. Problems can involve durable medical equipment, home health services, pharmacy claims, managed-care payments, electronic-funds-transfer diversion, or organized criminal activity.
Fraud harms more than government budgets. False information can enter a patient’s medical record, creating confusion during later treatment. A person may receive an unnecessary procedure that exposes them to avoidable risk. Medical identity theft can interfere with billing and coverage, while funds lost through fraudulent claims are unavailable for legitimate care. HHS-OIG has also warned that fraudsters target beneficiaries directly through scams designed to obtain Medicare or Medicaid information. Protecting the programs therefore requires both financial controls and beneficiary education.
Improper payment is broader than intentional fraud. Some claims are paid incorrectly because of documentation failures, coding mistakes, eligibility errors, or administrative complexity rather than deliberate deception. Effective oversight must distinguish intentional misconduct from honest error. Treating every mistake as fraud can discourage provider participation and create excessive compliance costs, while weak enforcement allows deliberate overbilling to become profitable. Audits, data analysis, clear billing rules, appeals, and proportionate penalties are all necessary to maintain that distinction.
Private Contractors and Medicare Advantage
Government programs rely heavily on private organizations. Contractors process claims, administer benefits, provide equipment, manage pharmacy services, perform audits, and operate Medicare Advantage plans. Private participation can provide expertise, coordinated care, and additional benefits, but it also creates financial incentives that require oversight. A company paid to manage care may have incentives to reduce unnecessary spending, yet it may also have incentives to restrict services, increase administrative revenue, or document beneficiaries in ways that raise payments.
Medicare Advantage illustrates this tension. Private insurers receive risk-adjusted payments to provide Medicare-covered services, and many plans also offer benefits such as dental, vision, fitness, or reduced cost sharing. Supporters value coordinated care and additional benefits, while critics focus on prior authorization, network restrictions, marketing practices, and the possibility of overpayment through diagnosis coding. In May 2025, the Centers for Medicare & Medicaid Services announced a major expansion of Medicare Advantage audits, including plans to audit all eligible contracts for each payment year in newly initiated audits and to accelerate older audits. The policy reflects the importance of verifying that risk-adjusted payments correspond to accurate clinical information rather than simply accepting plan-submitted data.
Oversight should also protect beneficiaries from confusion. Advertising and enrollment materials need to explain clearly that Medicare Advantage plans are privately administered even though they provide Medicare benefits. Patients should be able to compare premiums, provider networks, prior-authorization rules, drug coverage, out-of-pocket limits, and supplemental benefits in understandable language. Competition among plans is useful only when beneficiaries can evaluate the choices and when payment methods do not reward inaccurate documentation.
Prescription Drugs, Provider Payment, and High Healthcare Costs
High healthcare spending creates another environment in which waste and profiteering can occur. U.S. costs reflect many factors, including hospital prices, specialist services, prescription drugs, administrative overhead, chronic disease, technology, and fragmented financing. High spending does not automatically indicate fraud, and low spending does not automatically indicate efficiency. A hospital treating severely ill patients can be expensive for legitimate reasons, while unnecessary testing or inflated prices can also increase costs without improving outcomes.
Prescription drugs are a major concern because patients and public programs may pay high prices for products that have limited competition. Generic medicines and biosimilars can reduce costs, but patents, market structure, production shortages, and legal strategies can delay competition. Medicare’s authority to negotiate prices for selected drugs has expanded in recent years, changing a system in which federal negotiation had historically been limited. The policy goal is not simply to make every medicine as cheap as possible; it is to balance affordability, access, and incentives for meaningful innovation while preventing monopoly power from producing unnecessary financial barriers.
Provider payment also shapes behavior. Traditional fee-for-service systems pay for each visit, test, procedure, or treatment, which can reward higher volume even when additional services do not improve health. Value-based payment attempts to connect reimbursement more closely to quality, outcomes, prevention, or coordinated care. That approach can reduce some volume incentives but creates its own challenges because quality measures may be difficult to design and providers caring for medically or socially complex populations can appear to perform worse if risk adjustment is inadequate. Payment reform therefore requires careful measurement rather than assuming that one reimbursement model will eliminate unnecessary spending.
Technology, Whistleblowers, and Beneficiary Protection
Data analysis can help detect unusual billing patterns across millions of claims. Algorithms may identify providers who bill implausibly high volumes, submit incompatible combinations of services, or show patterns that differ sharply from comparable providers. Such systems are useful for screening, but statistical abnormalities do not prove fraud. A specialist practice or unusual patient population may have legitimate reasons for atypical billing. Data tools should therefore support investigation rather than replace human review, evidence, and due process.
Recent oversight also shows that digital payment systems create new vulnerabilities. HHS-OIG reported in 2025 that entities processing Medicare and Medicaid payments had been targeted by electronic-funds-transfer fraud schemes in which criminals attempted to redirect provider payments. This type of fraud demonstrates that program integrity is no longer only about detecting false medical claims; cybersecurity, account verification, email compromise, and payment authentication are now part of protecting public healthcare funds.
Whistleblowers can be particularly valuable because employees and contractors may see false billing or kickback arrangements before regulators do. Federal and state laws provide channels for reporting fraud, and some false-claims cases allow qualifying whistleblowers to share in recoveries. Organizations should maintain internal reporting systems and protect people who raise concerns from retaliation, but internal policies should not prevent lawful reporting to government authorities. Beneficiaries also have a role. Reviewing Medicare Summary Notices or benefit statements, questioning services they did not receive, protecting identification numbers, and reporting suspicious activity can help identify fraud earlier.
Medicaid Access, Eligibility, and Program Integrity
Medicaid presents a different administrative challenge because it is jointly financed by federal and state governments and eligibility rules vary. Income, age, disability, pregnancy, family status, and state policy can all affect qualification. Complex enrollment procedures and frequent eligibility reviews may cause eligible people to lose coverage because of paperwork, missed notices, or income-verification problems. These coverage interruptions can disrupt medication, primary care, mental-health treatment, and chronic-disease management and may ultimately increase emergency-care costs.
Program integrity should therefore distinguish between deliberate ineligibility and administrative churn. Simplifying applications, using reliable income data already available to government, providing language assistance, and giving beneficiaries clear notice can reduce erroneous loss of coverage while still allowing states to verify eligibility. Anti-fraud systems that are excessively burdensome may save little money if they prevent eligible people from receiving preventive care and instead shift costs to hospitals or emergency departments.
Medicaid beneficiaries may also face social conditions that influence healthcare use, including unstable housing, food insecurity, disability, transportation problems, or lack of nearby providers. Healthcare programs cannot solve every social problem, but coordination with home-based services, behavioral health, nutrition support, and long-term care can improve outcomes. Cost control should not become a reason to deny medically necessary care, just as the existence of legitimate needs should not excuse fraudulent billing.
Building Stronger Oversight Without Undermining Care
Reform should focus on the points where financial incentives and weak information create preventable loss. Stronger auditing, claims analysis, data sharing, provider screening, cybersecurity, and enforcement can reduce fraud. Penalties need to be large enough that intentional misconduct is not treated as a cost of doing business. At the same time, regulators should provide clear standards and appeal procedures so legitimate providers can correct errors without facing disproportionate punishment.
Private plans and contractors can also be required to provide greater transparency about ownership, denials, complaints, quality measures, prior authorization, and financial performance. Medicare Advantage audits are particularly important because risk-adjusted payments depend on accurate diagnosis data. Drug-price policy can encourage competition and negotiation where appropriate, while payment reform can reward prevention and coordination without penalizing providers who care for high-risk patients.
Administrative simplification is another form of program integrity. Complex rules consume staff time, confuse beneficiaries, and create billing errors that may look like fraud. Clearer enrollment systems, standardized electronic processes, and better information exchange can reduce both accidental mistakes and opportunities for manipulation. Investment in primary care, home-based services, mental-health treatment, and chronic-disease management can also reduce avoidable hospitalization and improve the value of public spending.
Conclusion
Medicare and Medicaid are too important to be evaluated only through the size of their budgets or the existence of fraud. They provide healthcare to millions of older adults, people with disabilities, children, families, and low-income individuals, while also operating through some of the most complicated payment systems in the U.S. economy. That complexity creates real opportunities for false claims, overpayment, identity theft, inappropriate risk coding, unnecessary services, and cyber-enabled diversion of payments.
The appropriate response is stronger program integrity combined with protection of legitimate access. Fraud investigations, Medicare Advantage audits, secure payment systems, whistleblower protections, beneficiary education, and transparent contractor oversight can reduce financial loss. At the same time, eligibility procedures, payment rules, and cost-control strategies should not create barriers that prevent eligible patients from receiving necessary care. Public healthcare funds should be managed with both stewardship and clinical purpose: taxpayers deserve protection from fraud, and beneficiaries deserve a system in which oversight improves rather than obstructs access to appropriate healthcare.
References
U.S. Department of Health and Human Services Office of Inspector General. (n.d.). Fraud. https://oig.hhs.gov/fraud/
Centers for Medicare & Medicaid Services. (2025). CMS Rolls Out Aggressive Strategy to Enhance and Accelerate Medicare Advantage Audits.
Medicare Payment Advisory Commission. (2025). Reports to the Congress. https://www.medpac.gov/document-type/report/
Academic Master Education Team is a group of academic editors and subject specialists responsible for producing structured, research-backed essays across multiple disciplines. Each article is developed following Academic Master’s Editorial Policy and supported by credible academic references. The team ensures clarity, citation accuracy, and adherence to ethical academic writing standards
Content reviewed under Academic Master Editorial Policy.
